To evaluate mHAdLyp.sT’s effects on 4T1 tumor growth and metastasis we compare it with ICIs (anti-PD-1 and anti-CTLA-4 antibodies) and assess if it can synergize with ICIs to inhibit tumor growth and metastasis. Here, CTLA4 is linked to neoplasm.